Literature DB >> 17304869

Clinical presentations of parvovirus B19 infection.

Jessica T Servey1, Brian V Reamy, Joshua Hodge.   

Abstract

Although most persons with parvovirus B19 infection are asymptomatic or have mild, nonspecific, cold-like symptoms, several clinical conditions have been linked to the virus. Parvovirus B19 usually infects children and causes the classic "slapped-cheek" rash of erythema infectiosum (fifth disease). The virus is highly infectious and spreads mainly through respiratory droplets. By the time the rash appears, the virus is no longer infectious. The virus also may cause acute or persistent arthropathy and papular, purpuric eruptions on the hands and feet ("gloves and socks" syndrome) in adults. Parvovirus B19 infection can trigger an acute cessation of red blood cell production, causing transient aplastic crisis, chronic red cell aplasia, hydrops fetalis, or congenital anemia. This is even more likely in patients with illnesses that have already shortened the lifespan of erythrocytes (e.g., iron deficiency anemia, human immunodeficiency virus, sickle cell disease, thalassemia, spherocytosis). A clinical diagnosis can be made without laboratory confirmation if erythema infectiosum is present. If laboratory confirmation is needed, serum immunoglobulin M testing is recommended for immunocompetent patients; viral DNA testing is recommended for patients in aplastic crisis and for those who are immunocompromised. Treatment is usually supportive, although some patients may require transfusions or intravenous immune globulin therapy. Most patients recover completely.

Entities:  

Mesh:

Year:  2007        PMID: 17304869

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  37 in total

1.  Aplastic crisis induced by human parvovirus B19 infection as an initial presentation of hereditary spherocytosis.

Authors:  Betul Tavil; Semanur Ozdel; Serdar Ozkasap; Nese Yarali; Bahattin Tunc
Journal:  Indian J Pediatr       Date:  2010-09-25       Impact factor: 1.967

Review 2.  Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Gabriele Calizzani; Fabio Candura; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

3.  Epidemiological and clinical characteristics of human parvovirus B19 infections during 2006-2009 in Northern Greece.

Authors:  M Exindari; D Chatzidimitriou; A Melidou; G Gioula; L Ziogou; E Diza
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

4.  Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.

Authors:  Jan Bieri; Carlos Ros
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

5.  Characterization of the early steps of human parvovirus B19 infection.

Authors:  Silva Quattrocchi; Nico Ruprecht; Claudia Bönsch; Sven Bieli; Christoph Zürcher; Klaus Boller; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

Review 6.  Exposure to fifth disease in pregnancy.

Authors:  Arthur Staroselsky; Chagit Klieger-Grossmann; Facundo Garcia-Bournissen; Gideon Koren
Journal:  Can Fam Physician       Date:  2009-12       Impact factor: 3.275

7.  Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen.

Authors:  Bor-Show Tzang; Der-Yuan Chen; Chun-Chou Tsai; Szu-Yi Chiang; Tsung-Ming Lin; Tsai-Ching Hsu
Journal:  J Biomed Sci       Date:  2010-05-25       Impact factor: 8.410

Review 8.  The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.

Authors:  Ranran Zhang; Mithun Vinod Shah; Thomas P Loughran
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

9.  Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.

Authors:  Remo Leisi; Nico Ruprecht; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

10.  Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice.

Authors:  Tsai-Ching Hsu; Chun-Ching Chiu; Shun-Chih Chang; Hsu-Chin Chan; Ya-Fang Shi; Tzy-Yen Chen; Bor-Show Tzang
Journal:  Virulence       Date:  2015-12-02       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.